Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Adel A. Alharf"'
Autor:
Osama A. AlKhamees, Khaled A. AlNemer, Mohammed W. Bin Maneea, Faisal A. AlSugair, Bassam H. AlEnizi, Adel A. Alharf
Publikováno v:
Saudi Pharmaceutical Journal, Vol 26, Iss 2, Pp 211-216 (2018)
Medications usage has become a significant part of contemporary life. Many studies indicate that there is an excessive use and a considerable waste of medicines. This descriptive study aims at identifying the most used medicines in Saudi Arabia from
Externí odkaz:
https://doaj.org/article/3800bf4cae244768ae5fd1e3d17667d2
Autor:
Mubarak Alshahrani, Ali Alshahrani, Nasser Alqahtani, Saleh A. Bawazir, Ghazi Saeed, Mohammed Alquwaizani, Adel A. Alharf, Nasser Aljasser
Publikováno v:
Saudi Pharmaceutical Journal, Vol 26, Iss 3, Pp 388-395 (2018)
Pharmacovigilance is vital to public health. Adopting a robust spontaneous reporting system for adverse drug events can counteract most hazards that arise from utilizing medicinal products. Prior to the establishment of the Saudi Food and Drug Author
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::305894b2ca998b24cb9a46b49505f5b5
https://europepmc.org/articles/PMC5856944/
https://europepmc.org/articles/PMC5856944/
Autor:
Arab OO; Clinical Trials Department Benefit and Risk Assessment Executive Directorate Drug Sector - Saudi Food and Drug Authority, Riyadh, 13513- 7148, Saudi Arabia. ooarab@sfda.gov.sa., Aldayan M; Clinical Trials Department Benefit and Risk Assessment Executive Directorate Drug Sector - Saudi Food and Drug Authority, Riyadh, 13513- 7148, Saudi Arabia., Almowaizri K; Clinical Trials Department Benefit and Risk Assessment Executive Directorate Drug Sector - Saudi Food and Drug Authority, Riyadh, 13513- 7148, Saudi Arabia., Alghamdi A; Clinical Trials Department Benefit and Risk Assessment Executive Directorate Drug Sector - Saudi Food and Drug Authority, Riyadh, 13513- 7148, Saudi Arabia., Alghamdi J; Clinical Trials Department Benefit and Risk Assessment Executive Directorate Drug Sector - Saudi Food and Drug Authority, Riyadh, 13513- 7148, Saudi Arabia., Alharf A; Clinical Trials Department Benefit and Risk Assessment Executive Directorate Drug Sector - Saudi Food and Drug Authority, Riyadh, 13513- 7148, Saudi Arabia.
Publikováno v:
Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2024 Dec 26. Date of Electronic Publication: 2024 Dec 26.
Autor:
Alnafisah AY; Efficacy and Safety Evaluation Department, Benefit and Risk Evaluation Directorate, Saudi Food and Drug Authority (SFDA), Riyadh, Saudi Arabia., Alkhalidi AF; Efficacy and Safety Evaluation Department, Benefit and Risk Evaluation Directorate, Saudi Food and Drug Authority (SFDA), Riyadh, Saudi Arabia., Aljohani H; Efficacy and Safety Evaluation Department, Benefit and Risk Evaluation Directorate, Saudi Food and Drug Authority (SFDA), Riyadh, Saudi Arabia., Almutairi M; Efficacy and Safety Evaluation Department, Benefit and Risk Evaluation Directorate, Saudi Food and Drug Authority (SFDA), Riyadh, Saudi Arabia., Alharf A; Drug Sector, Saudi Food and Drug Authority (SFDA), Riyadh, Saudi Arabia., Alkofide H; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Publikováno v:
Clinical epidemiology [Clin Epidemiol] 2024 May 23; Vol. 16, pp. 357-365. Date of Electronic Publication: 2024 May 23 (Print Publication: 2024).
Autor:
Fernandes EAF; Agência Nacional de Vigilância Sanitária, Brasília, Brazil., van Oudtshoorn J; South African Health Products Regulatory Authority, Pretoria, South Africa., Tam A; Health Canada, Ottawa, ON, Canada., González LCA; Instituto Nacional de Vigilancia de Medicamentos y Alimentos, Bogota, Colombia., Aurela EG; Instituto Nacional de Vigilancia de Medicamentos y Alimentos, Bogota, Colombia., Potthast H; Federal Institute for Drugs and Medical Devices, Bonn, Germany., Mettke K; Federal Institute for Drugs and Medical Devices, Bonn, Germany., Kuribayashi R; Ministry of Health, Labour and Welfare/Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Shimojo K; Ministry of Health, Labour and Welfare/Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Kasuga M; Ministry of Health, Labour and Welfare/Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Morales L; Comisión Federal para la Protección contra Riesgos Sanitarios, Ciudad de Mexico, México., Rodríguez Z; Comisión Federal para la Protección contra Riesgos Sanitarios, Ciudad de Mexico, México., Jones B; Medsafe, Wellington, New Zealand., Ahn C; Ministry of Food and Drug Safety, Cheongju-si, Republic of Korea., Yun E; Ministry of Food and Drug Safety, Cheongju-si, Republic of Korea., Kim SH; Ministry of Food and Drug Safety, Cheongju-si, Republic of Korea., Rodrigues C; Health Sciences Authority, Singapore, Singapore., Tiong T; Health Sciences Authority, Singapore, Singapore., Crane C; Therapeutic Goods Administration, Canberra, NSW, Australia., Walther C; Swissmedic, Bern, Switzerland., Roost MS; Swissmedic, Bern, Switzerland., Chen TL; Taiwan Food and Drug Administration, Taipei, Taiwan., Hsu LF; Center for Drug Evaluation, Taipei, Taiwan., Braddy AC; Food and Drug Administration, Silver Spring, MD, United States., García-Arieta A; WHO-Observer, Geneva, Switzerland.; Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain., Abalos I; Administración Nacional de Medicamentos, Alimentos y Tecnología, Buenos Aires, Argentina., Divinsky M; Center for Pharmaceutical and Enforcement Division, Jerusalem, Israel., Alsuwyeh A; Saudi Food and Drug Authority, Riyadh, Saudi Arabia., Alzenaidy B; Saudi Food and Drug Authority, Riyadh, Saudi Arabia., Alharf A; Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
Publikováno v:
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques [J Pharm Pharm Sci] 2024 Mar 21; Vol. 27, pp. 12398. Date of Electronic Publication: 2024 Mar 21 (Print Publication: 2024).
Autor:
Ammari MA; Pharmaceutical Care Services, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Almuzzaini B; Medical Genomics Research Department, King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Al Sulaiman K; Pharmaceutical Care Services, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center (KAIMRC), PO Box 22490, 11426, Riyadh, Saudi Arabia.; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.; Saudi Critical Care Pharmacy Research (SCAPE) Platform, Riyadh, Saudi Arabia., AlBalwi M; Department of Pathology and laboratory, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia., Sultana K; Research Office, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia., Alabdulkareem IB; Health Sciences Research Center, King Abdullah Bin Abdulaziz University Hospital, Princess Nourah bint Abdulrahman University, Riyadh, Kingdom of Saudi Arabia., Almakhlafi NS; Pharmaceutical Care Services, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Humoud AA; Pharmaceutical Care Services, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Waheeby M; Pharmaceutical Care Services, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Balla M; Pharmaceutical Care Services, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Shehri AA; Pharmaceutical Care Services, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Alharf A; Saudi Food and Drug Authority, Drug Sector, Riyadh, Saudi Arabia., Alghamdi J; Saudi Food and Drug Authority, Drug Sector, Riyadh, Saudi Arabia. AlghamdiJahad7@gmail.com.
Publikováno v:
The pharmacogenomics journal [Pharmacogenomics J] 2023 Jul; Vol. 23 (4), pp. 82-88. Date of Electronic Publication: 2023 Feb 04.
Autor:
Almoteiry K; Saudi Health Council, Riyadh, Saudi Arabia., Alharf A; Saudi Food and Drug Authority, Riyadh, Saudi Arabia., Al Hammad B; Saudi Food and Drug Authority, Riyadh, Saudi Arabia., Aljuffali I; Ministry of Health, Riyadh, Saudi Arabia., Al-Azemi N; Saudi Health Council, Riyadh, Saudi Arabia., Al-Ghaith T; Saudi Health Council, Riyadh, Saudi Arabia., Alhomidi S; Saudi Health Council, Riyadh, Saudi Arabia., Alshehri A; Saudi Health Council, Riyadh, Saudi Arabia., Seiter A; The World Bank Group, Washington, DC, United States of America., Herbst C; The World Bank Group, Washington, DC, United States of America., Pisani E; Policy Institute, King's College London, Virginia Woolf Building, 22 Kingsway, London WC2B 6LE, England.
Publikováno v:
Bulletin of the World Health Organization [Bull World Health Organ] 2022 Aug 01; Vol. 100 (8), pp. 511-519. Date of Electronic Publication: 2022 Jun 22.
Autor:
Alghamdi J; Saudi Biobank, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard - Health Affairs (MNG-HA), P.O. Box 3660, 11481 Mail Code, Riyadh, 1515, Saudi Arabia. Alghamdija@ngha.med.sa., Alqadi A; Pharmacy Services Department, Security Forces Hospital Program, Riyadh, Saudi Arabia., Alharf A; Saudi Food and Drug Authority, Riyadh, Saudi Arabia., Almuzzaini B; Medical Genomics Research Department, King Abdullah International Medical Research, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia., Mahmud A; King Abdul Aziz Cardiac Center, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia., Barhoumi T; Core Facility, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia., Badreldin HA; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia., Alaamery M; Developmental Medicine Department, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia., Padmanabhan S; British Heart Foundation Glasgow Cardiovascular Research Centre(GCRC), Institute of Cardiovascular and Medical Sciences, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK. Sandosh.Padmanabhan@glasgow.ac.uk.
Publikováno v:
European journal of clinical pharmacology [Eur J Clin Pharmacol] 2020 Dec; Vol. 76 (12), pp. 1745-1754. Date of Electronic Publication: 2020 Jul 21.
Autor:
Alharf A; Saudi Food and Drug Authority, Saudi Arabia., Alqahtani N; Saudi Food and Drug Authority, Saudi Arabia., Saeed G; Saudi Food and Drug Authority, Saudi Arabia., Alshahrani A; Saudi Food and Drug Authority, Saudi Arabia., Alshahrani M; Saudi Food and Drug Authority, Saudi Arabia., Aljasser N; Saudi Food and Drug Authority, Saudi Arabia., Alquwaizani M; Saudi Food and Drug Authority, Saudi Arabia., Bawazir S; King Saud University, Saudi Arabia.
Publikováno v:
Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society [Saudi Pharm J] 2018 Mar; Vol. 26 (3), pp. 388-395. Date of Electronic Publication: 2018 Jan 04.